Study of DM5167 in Patients With Advanced Solid Tumors

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 24, 2024

Primary Completion Date

October 30, 2026

Study Completion Date

January 31, 2027

Conditions

Advanced Breast Cancer

Interventions

DRUG

DM5167

Once daily for 28 days

Trial Locations (4)

RECRUITING

Seoul National University Bundang Hospital, Gyeonggi-do

RECRUITING

Samsung Medical Center, Seoul

RECRUITING

Seoul National University Hospital, Seoul

RECRUITING

Severance Hospital, Seoul